Top Markets
Coin of the day
Promore Pharma AB (publ) Promore Pharma AB (publ)

Promore Pharma AB (publ)

PROMO
Kedudukan dalam Saham #25506
Promore Pharma AB (publ) is a Swedish biopharmaceutical firm dedicated to... Promore Pharma AB (publ) is a Swedish biopharmaceutical firm dedicated to advancing peptide-based drug therapies. The company's development pipeline features PXL01, currently undergoing Phase IIa studies for its potential in preventing post-surgical adhesions and scars, mitigating dermal scarring, and aiding hand tendon repair. Another key asset, LL-37, is engaged in Phase IIb clinical trials to address venous leg ulcers, stimulate the healing of persistent wounds, and treat diabetic foot ulcers. Additionally, Promore Pharma has partnered with Fidia Farmaceutici S.p.A. for the production of hyaluronic acid syringes. Founded in 2002, the company, formerly known as Lipopeptide AB until its rebranding in January 2017, maintains its headquarters in Solna, Sweden.
Harga Saham
$1.34
Disegerakkan terakhir: 2024-02-14
Modal Pasaran
$48.96M
Perubahan (1 hari)
-12.94%
Perubahan (1 tahun)
0.00%
Negara
SE
Perdagangan Promore Pharma AB (publ) (PROMO)

Kategori

Sejarah harga saham bagi Promore Pharma AB (publ) (PROMO)
Harga penutupan tertinggi: $2.11 pada 2024-02-01

Harga penutupan terendah: $179.71 pada 2017-07-01
Sejarah harga saham Promore Pharma AB (publ) dari 2017 hingga 2026
Prestasi harga saham tahunan
Tahun Prestasi
2024 54.03%
2023 -86.45%
2022 -51.13%
2021 -52.08%
2020 -18.70%
2019 -67.83%
2018 -5.69%
2017 0.00%
Harga saham bagi syarikat atau pesaing serupa
Syarikat Harga saham Perubahan 1thn% Negara
$539.14 35.65%
US
$1.04K 56.21%
NL
$118.33 -18.49%
AU
$761.87 8.65%
CH
$130.43 397.46%
US